The clinical information you need, at your fingertips.

Medical News for You

FDA

FDA greenlights Weltruza, first monthly subcutaneous olanzapine

The long-acting formulation for schizophrenia requires no loading doses, oral supplementation, or post-injection monitoring. . .

N Engl J Med

Gene therapy plus goggles may restore limited vision in retinitis pigmentosa

Small early-stage trial found improved light sensitivity and object detection in some participants with profound vision loss. . .

BMJ

HPV vaccination before pregnancy linked to lower odds of preterm birth

Cochrane Database Syst Rev

Medical cannabis for insomnia? Evidence remains uncertain

JAMA Netw Open

Flu during pregnancy: Does it affect a child’s mental health?

Large Korea-Japan study found a modest population-level association that disappeared in sibling analyses. . .

FDA

Hovilpri approved as first-in-class treatment for refractory HSV

JAMA Psychiatry

ADHD may leave a cognitive mark decades later

JAMA

NAD booster misses the mark in early Parkinson's disease

Drug pipeline

Broader pneumococcal vaccine meets phase 3 immune-response goals

Investigational VAX-31 combines all bacterial types targeted by Prevnar 20 and Capvaxive, plus three additional types. . .